Home › Lupus › New York › New York City
Studi clinici su Lupus a New York City, NY
18 studi su Lupus cercano partecipanti presso sedi a New York City e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
In reclutamentoFase 2
- Columbia University Medical Center, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
In reclutamentoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
In reclutamentoFase 3
- Sl0044 50077, New York
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
In reclutamentoFase 3
- Research Site, New York
HEALTH Home Urinalysis Testing
In reclutamento
- NYU Langone Health, New York
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
In reclutamentoFase 1/2
- Research Site, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
In reclutamentoFase 1
- Icahn School of Medicine at Mount Sinai, New York
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
In reclutamentoFase 4
- New York University School Of Medicine, New York
Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
In reclutamentoFase 2
- Icahn School of Medicine at Mount Sinai, New York
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
In reclutamentoFase 3
- VA NY Harbor Healthcare System, New York
- NYC Health + Hospitals/Bellevue, New York
- NYU Langone Health, New York
- e altri 2
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
In reclutamentoFase 2
- NYU Langone Health, New York
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
In reclutamentoFase 1
- Columbia University Medical Center, New York
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
In reclutamentoFase 1
- Montefiore Medical Center, New York
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- NYU Langone Medical Center/Hospital for Joint Diseases, New York
- Hospital for Special Surgery, New York
Alnuctamab for Refractory SLE (LATTE Study)
In reclutamentoFase 1
- Icahn School of Medicine at Mount Sinai, New York
Lupus Landmark Study: A Prospective Registry and Biorepository
In reclutamentoStudio osservazionale
- Columbia University Medical Center, New York
- Northwell Health, New York
Safety of the Herpes Zoster Subunit Vaccine in Lupus
In reclutamentoFase 4
- NYU Langone Health, New York
Safety and Efficacy of ONT01 in Lupus
In reclutamentoFase 1 iniziale
- Hospital for Special Surgery, New York
Studi su Lupus in altre città
- Houston, TX13 studi
- Durham, NC12 studi
- Miami, FL11 studi
- Washington, DC10 studi
- Tampa, FL9 studi
- Philadelphia, PA9 studi
- Clearwater, FL8 studi
- Santa Monica, CA8 studi
- Oklahoma City, OK8 studi
- Los Angeles, CA8 studi
- Boston, MA8 studi
- Chicago, IL8 studi
Altri studi a New York City
- Cancro al seno136 studi
- Cancro del polmone non a piccole cellule121 studi
- Cancro (tutti i tipi)109 studi
- Cancro alla prostata103 studi
- Cancro metastatico93 studi
- Cancro colorettale78 studi
- Cancro ovarico69 studi
- Cancro ai polmoni60 studi
- Mieloma multiplo60 studi
- Cancro pancreatico60 studi
- Cancro dell'endometrio52 studi
- Leucemia mieloide acuta51 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.